Sanjeev Vasishtha, MD - Medicare Pediatrics in Center Valley, PA

Sanjeev Vasishtha, MD is a medicare enrolled "Pediatrics" physician in Center Valley, Pennsylvania. His current practice location is 3800 Sierra Cir, Suite 100, Center Valley, Pennsylvania. You can reach out to his office (for appointments etc.) via phone at (484) 664-2090.

Sanjeev Vasishtha is licensed to practice in Pennsylvania (license number MD433822) and he also participates in the medicare program. He does not accept medicare assignments directly but he may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. His NPI Number is 1881684975.

Contact Information

Sanjeev Vasishtha, MD
3800 Sierra Cir, Suite 100,
Center Valley, PA 18034-8476
(484) 664-2090
(484) 664-2098



Physician's Profile

Full NameSanjeev Vasishtha
GenderMale
SpecialityPediatrics
Location3800 Sierra Cir, Center Valley, Pennsylvania
Accepts Medicare AssignmentsMedicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.
  NPI Data:
  • NPI Number: 1881684975
  • Provider Enumeration Date: 10/28/2005
  • Last Update Date: 04/16/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 2264577337
  • Enrollment ID: I20110601000395

Medical Identifiers

Medical identifiers for Sanjeev Vasishtha such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1881684975NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
208000000XPediatrics MD433822 (Pennsylvania)Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Sanjeev Vasishtha allows following entities to bill medicare on his behalf.
Entity NameLehigh Valley Physician Group
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1457309650
PECOS PAC ID: 3072425123
Enrollment ID: O20040227000335

News Archive

New drug offers promising possibility for treating adults with periodontitis

Nearly half of all adults in the United States suffer from the gum disease periodontitis, and 8.5 percent have a severe form that can raise the risk of heart disease, diabetes, arthritis and pregnancy complications.

Viewpoints: Slowing health costs; possibility of Medicaid deal in virginia; a new name for brain death

For decades a common refrain was that the rapid rise in health spending hurt the competitiveness of American businesses and ate into workers' take-home pay. Businesses and politicians from both sides of the aisle agreed that something had to be done to slow the growth of health-care costs.

New York Governor participates in roundtable discussion on stem cell research

Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today. Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein, and eight stem cell researchers discussed advances in medical therapies and treatments that Einstein scientists have been investigating since receiving more than $14 million in State funding for stem cell research.

Infectious disease experts examine how quickly Lyme disease symptoms resolve in children

For many Americans, the warmer weather of summer means more time spent outside: More gardening and yard work, more hikes in the woods, more backyard barbecues. But for this year in particular, some experts predict warmer weather will lead to more ticks.

Study explores high-risk therapeutic devices approved through FDA's PMA pathway

Of high-risk therapeutic devices approved via the Food and Drug Administration Premarket Approval (PMA) pathway between 2010 and 2011, there has been wide variation in both the number and quality of premarket and postmarket studies, with approximately 13 percent of initiated postmarket studies completed between 3 and 5 years after FDA approval, according to a study in the August 11 issue of JAMA.

Read more Medical News

› Verified 3 days ago

Entity NameGood Shepherd Rehabilitation Hospital
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1427035039
PECOS PAC ID: 9335032390
Enrollment ID: O20040301000379

News Archive

New drug offers promising possibility for treating adults with periodontitis

Nearly half of all adults in the United States suffer from the gum disease periodontitis, and 8.5 percent have a severe form that can raise the risk of heart disease, diabetes, arthritis and pregnancy complications.

Viewpoints: Slowing health costs; possibility of Medicaid deal in virginia; a new name for brain death

For decades a common refrain was that the rapid rise in health spending hurt the competitiveness of American businesses and ate into workers' take-home pay. Businesses and politicians from both sides of the aisle agreed that something had to be done to slow the growth of health-care costs.

New York Governor participates in roundtable discussion on stem cell research

Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today. Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein, and eight stem cell researchers discussed advances in medical therapies and treatments that Einstein scientists have been investigating since receiving more than $14 million in State funding for stem cell research.

Infectious disease experts examine how quickly Lyme disease symptoms resolve in children

For many Americans, the warmer weather of summer means more time spent outside: More gardening and yard work, more hikes in the woods, more backyard barbecues. But for this year in particular, some experts predict warmer weather will lead to more ticks.

Study explores high-risk therapeutic devices approved through FDA's PMA pathway

Of high-risk therapeutic devices approved via the Food and Drug Administration Premarket Approval (PMA) pathway between 2010 and 2011, there has been wide variation in both the number and quality of premarket and postmarket studies, with approximately 13 percent of initiated postmarket studies completed between 3 and 5 years after FDA approval, according to a study in the August 11 issue of JAMA.

Read more Medical News

› Verified 3 days ago

Entity NameSchuylkill Health System Medical Group, Inc.
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1588603567
PECOS PAC ID: 0840285532
Enrollment ID: O20040420001197

News Archive

New drug offers promising possibility for treating adults with periodontitis

Nearly half of all adults in the United States suffer from the gum disease periodontitis, and 8.5 percent have a severe form that can raise the risk of heart disease, diabetes, arthritis and pregnancy complications.

Viewpoints: Slowing health costs; possibility of Medicaid deal in virginia; a new name for brain death

For decades a common refrain was that the rapid rise in health spending hurt the competitiveness of American businesses and ate into workers' take-home pay. Businesses and politicians from both sides of the aisle agreed that something had to be done to slow the growth of health-care costs.

New York Governor participates in roundtable discussion on stem cell research

Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today. Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein, and eight stem cell researchers discussed advances in medical therapies and treatments that Einstein scientists have been investigating since receiving more than $14 million in State funding for stem cell research.

Infectious disease experts examine how quickly Lyme disease symptoms resolve in children

For many Americans, the warmer weather of summer means more time spent outside: More gardening and yard work, more hikes in the woods, more backyard barbecues. But for this year in particular, some experts predict warmer weather will lead to more ticks.

Study explores high-risk therapeutic devices approved through FDA's PMA pathway

Of high-risk therapeutic devices approved via the Food and Drug Administration Premarket Approval (PMA) pathway between 2010 and 2011, there has been wide variation in both the number and quality of premarket and postmarket studies, with approximately 13 percent of initiated postmarket studies completed between 3 and 5 years after FDA approval, according to a study in the August 11 issue of JAMA.

Read more Medical News

› Verified 3 days ago

Entity NameHazleton Professional Services
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1952464638
PECOS PAC ID: 8022110402
Enrollment ID: O20070305000195

News Archive

New drug offers promising possibility for treating adults with periodontitis

Nearly half of all adults in the United States suffer from the gum disease periodontitis, and 8.5 percent have a severe form that can raise the risk of heart disease, diabetes, arthritis and pregnancy complications.

Viewpoints: Slowing health costs; possibility of Medicaid deal in virginia; a new name for brain death

For decades a common refrain was that the rapid rise in health spending hurt the competitiveness of American businesses and ate into workers' take-home pay. Businesses and politicians from both sides of the aisle agreed that something had to be done to slow the growth of health-care costs.

New York Governor participates in roundtable discussion on stem cell research

Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today. Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein, and eight stem cell researchers discussed advances in medical therapies and treatments that Einstein scientists have been investigating since receiving more than $14 million in State funding for stem cell research.

Infectious disease experts examine how quickly Lyme disease symptoms resolve in children

For many Americans, the warmer weather of summer means more time spent outside: More gardening and yard work, more hikes in the woods, more backyard barbecues. But for this year in particular, some experts predict warmer weather will lead to more ticks.

Study explores high-risk therapeutic devices approved through FDA's PMA pathway

Of high-risk therapeutic devices approved via the Food and Drug Administration Premarket Approval (PMA) pathway between 2010 and 2011, there has been wide variation in both the number and quality of premarket and postmarket studies, with approximately 13 percent of initiated postmarket studies completed between 3 and 5 years after FDA approval, according to a study in the August 11 issue of JAMA.

Read more Medical News

› Verified 3 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Sanjeev Vasishtha is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Sanjeev Vasishtha, MD
Po Box 1754,
Allentown, PA 18105-1754

Ph: () -
Sanjeev Vasishtha, MD
3800 Sierra Cir, Suite 100,
Center Valley, PA 18034-8476

Ph: (484) 664-2090

News Archive

New drug offers promising possibility for treating adults with periodontitis

Nearly half of all adults in the United States suffer from the gum disease periodontitis, and 8.5 percent have a severe form that can raise the risk of heart disease, diabetes, arthritis and pregnancy complications.

Viewpoints: Slowing health costs; possibility of Medicaid deal in virginia; a new name for brain death

For decades a common refrain was that the rapid rise in health spending hurt the competitiveness of American businesses and ate into workers' take-home pay. Businesses and politicians from both sides of the aisle agreed that something had to be done to slow the growth of health-care costs.

New York Governor participates in roundtable discussion on stem cell research

Albert Einstein College of Medicine of Yeshiva University hosted a roundtable discussion on stem cell research with New York Governor David A. Paterson today. Allen M. Spiegel, M.D., the Marilyn and Stanley M. Katz Dean of Einstein, and eight stem cell researchers discussed advances in medical therapies and treatments that Einstein scientists have been investigating since receiving more than $14 million in State funding for stem cell research.

Infectious disease experts examine how quickly Lyme disease symptoms resolve in children

For many Americans, the warmer weather of summer means more time spent outside: More gardening and yard work, more hikes in the woods, more backyard barbecues. But for this year in particular, some experts predict warmer weather will lead to more ticks.

Study explores high-risk therapeutic devices approved through FDA's PMA pathway

Of high-risk therapeutic devices approved via the Food and Drug Administration Premarket Approval (PMA) pathway between 2010 and 2011, there has been wide variation in both the number and quality of premarket and postmarket studies, with approximately 13 percent of initiated postmarket studies completed between 3 and 5 years after FDA approval, according to a study in the August 11 issue of JAMA.

Read more News

› Verified 3 days ago


Pediatrics Doctors in Center Valley, PA

Emily Kraus, M.D.
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 3800 Sierra Circle, Suite 100, Center Valley, PA 18034
Phone: 484-664-2090    Fax: 484-664-2098
Anuradha Rai, M.D.
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 3800 Sierra Cir Ste 100, Center Valley, PA 18034
Phone: 484-664-2090    Fax: 484-664-2089
Kelli Nicole Harajda-hurst, MD
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 3800 Sierra Cir Ste 100, Center Valley, PA 18034
Phone: 484-664-2090    Fax: 484-664-2089
Sarah Elizabeth Kleinle, DO
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 3800 Sierra Cir Ste 100, Center Valley, PA 18034
Phone: 484-664-2090    
Angela Marie Camasto, MD
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 3800 Sierra Cir, Suite 100, Center Valley, PA 18034
Phone: 484-664-2090    Fax: 484-664-2089
Dr. Katie Kindt, DO
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 3800 Sierra Cir Ste 100, Center Valley, PA 18034
Phone: 484-664-2090    Fax: 484-664-2089
Katherine Still, M.D.
Pediatrics
Medicare: Medicare Enrolled
Practice Location: 3800 Sierra Cir, Suite 100, Center Valley, PA 18034
Phone: 484-664-2090    Fax: 484-664-2089

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.